Hummers LK - Search Results

1

Cardiac complications of systemic sclerosis: recent progress in diagnosis.

Boueiz A, Mathai SC, Hummers LK, Hassoun PM. Boueiz A, et al. Among authors: hummers lk. Curr Opin Rheumatol. 2010 Nov;22(6):696-703. doi: 10.1097/BOR.0b013e32833dfbd8. Curr Opin Rheumatol. 2010. PMID: 20657283 Review.

2

The Utility of Plasma Vascular Biomarkers in Systemic Sclerosis: A Prospective Longitudinal Analysis.

Mecoli CA, Shah AA, Boin F, Wigley FM, Hummers LK. Mecoli CA, et al. Among authors: hummers lk. Arthritis Rheumatol. 2020 Aug;72(8):1341-1349. doi: 10.1002/art.41265. Epub 2020 Jul 20. Arthritis Rheumatol. 2020. PMID: 32200572 Free PMC article.

3

Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma.

Hummers LK, Wigley FM. Hummers LK, et al. Rheum Dis Clin North Am. 2003 May;29(2):293-313. doi: 10.1016/s0889-857x(03)00019-x. Rheum Dis Clin North Am. 2003. PMID: 12841296 Review.

4

Abnormal exhaled ethane concentrations in scleroderma.

Cope KA, Solga SF, Hummers LK, Wigley FM, Diehl AM, Risby TH. Cope KA, et al. Among authors: hummers lk. Biomarkers. 2006 Jan-Feb;11(1):70-84. doi: 10.1080/13547500500515046. Biomarkers. 2006. PMID: 16484138

5

A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma).

Roberts CG, Hummers LK, Ravich WJ, Wigley FM, Hutchins GM. Roberts CG, et al. Among authors: hummers lk. Gut. 2006 Dec;55(12):1697-703. doi: 10.1136/gut.2005.086074. Epub 2006 Mar 9. Gut. 2006. PMID: 16527835 Free PMC article.

6

Microvascular damage in systemic sclerosis: detection and monitoring with biomarkers.

Hummers LK. Hummers LK. Curr Rheumatol Rep. 2006 Apr;8(2):131-7. doi: 10.1007/s11926-006-0053-z. Curr Rheumatol Rep. 2006. PMID: 16569372 Review.

7

Antiangiogenic plasma activity in patients with systemic sclerosis.

Mulligan-Kehoe MJ, Drinane MC, Mollmark J, Casciola-Rosen L, Hummers LK, Hall A, Rosen A, Wigley FM, Simons M. Mulligan-Kehoe MJ, et al. Among authors: hummers lk. Arthritis Rheum. 2007 Oct;56(10):3448-58. doi: 10.1002/art.22861. Arthritis Rheum. 2007. PMID: 17907150 Free article.

8

High-dose cyclophosphamide without stem cell rescue in scleroderma.

Tehlirian CV, Hummers LK, White B, Brodsky RA, Wigley FM. Tehlirian CV, et al. Among authors: hummers lk. Ann Rheum Dis. 2008 Jun;67(6):775-81. doi: 10.1136/ard.2007.077446. Epub 2007 Nov 1. Ann Rheum Dis. 2008. PMID: 17974598 Clinical Trial.

9

Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.

Mittoo S, Wigley FM, Wise R, Xiao H, Hummers L. Mittoo S, et al. Arthritis Rheum. 2007 Dec;56(12):4195-202. doi: 10.1002/art.23077. Arthritis Rheum. 2007. PMID: 18050251 Free article.

10

Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG).

Blum M, Wigley FM, Hummers LK. Blum M, et al. Among authors: hummers lk. Medicine (Baltimore). 2008 Jan;87(1):10-20. doi: 10.1097/MD.0b013e3181630835. Medicine (Baltimore). 2008. PMID: 18204366 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results